Literature DB >> 3978310

Effects of anticonvulsants in vivo on high affinity choline uptake in vitro in mouse hippocampal synaptosomes.

J A Miller, J A Richter.   

Abstract

The effects of several anticonvulsant drugs on sodium-dependent high affinity choline uptake (HACU) in mouse hippocampal synaptosomes was investigated. HACU was measured in vitro after in vivo administration of the drug to mice. HACU was inhibited by drugs which have in common the ability to facilitate gamma-aminobutyric acid (GABA) transmission, pentobarbitone, phenobarbitone, barbitone, diazepam, chloridiazepoxide, and valproic acid. Dose-response relationships were determined for these drugs and the drugs' potencies at inhibiting HACU correlated well with their anticonvulsant potencies. Clonazepam, ethosuximide, carbamazepine, and barbituric acid had no effect on HACU in the doses used while phenytoin and trimethadione stimulated HACU. These results suggest that certain anticonvulsants may elicit a part of their anticonvulsant activity by modulating cholinergic neurones. This effect may be mediated through a GABA mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978310      PMCID: PMC1987204     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

Review 1.  The role of the neurotransmitters in the epilepsies.

Authors:  E W Maynert; T J Marczynski; R A Browning
Journal:  Adv Neurol       Date:  1975

2.  Effects of some anti-epileptic drugs on brain acetylcholine.

Authors:  C Bianchi; L Beani; A Bertelli
Journal:  Neuropharmacology       Date:  1975 May-Jun       Impact factor: 5.250

3.  Pentobarbital and in vivo turnover rate of acetylcholine in mouse brain and in regions of rat brain.

Authors:  M Trabucchi; D L Cheney; G Racagni; E Costa
Journal:  Pharmacol Res Commun       Date:  1975-02

4.  Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine.

Authors:  J R Simon; S Atweh; M J Kuhar
Journal:  J Neurochem       Date:  1976-05       Impact factor: 5.372

5.  Variation in acetylcholine content of the brain with physiological state.

Authors:  D RICHTER; J CROSSLAND
Journal:  Am J Physiol       Date:  1949-11

Review 6.  Neurotransmitter uptake: a tool in identifying neurotransmitter-specific pathways.

Authors:  M J Kuhar
Journal:  Life Sci       Date:  1973-12-16       Impact factor: 5.037

7.  K-Stimulated acetylcholine release: inhibition by several barbiturates and chloral hydrate but not by ethanol, chlordiazepoxide or 11-OH-delta9-tetrahydrocannabinol.

Authors:  J A Richter; L L Werling
Journal:  J Neurochem       Date:  1979-03       Impact factor: 5.372

8.  Effects of some cholinergic, adrenergic and serotoninergic compounds, glutamic acid and GABA on hippocampal seizures.

Authors:  A G Nasello; E S Marichich
Journal:  Pharmacology       Date:  1973       Impact factor: 2.547

9.  Antiepileptic drug development: II. Anticonvulsant drug screening.

Authors:  R L Krall; J K Penry; B G White; H J Kupferberg; E A Swinyard
Journal:  Epilepsia       Date:  1978-08       Impact factor: 5.864

10.  On the relationship between (3H)choline uptake activation and (3H)acetylcholine release.

Authors:  L C Murrin; R N DeHaven; M J Kuhar
Journal:  J Neurochem       Date:  1977-10       Impact factor: 5.372

View more
  4 in total

1.  Zebrafish assessment of cognitive improvement and anxiolysis: filling the gap between in vitro and rodent models for drug development.

Authors:  Edward D Levin
Journal:  Rev Neurosci       Date:  2011       Impact factor: 4.353

2.  Identification of Isthmin1 in the small annual fish, Nothobranchius guentheri, as a novel biomarker of aging and its potential rejuvenation activity.

Authors:  Congjun Li; Lili Song; Yang Zhou; Jiangshui Yuan; Shicui Zhang
Journal:  Biogerontology       Date:  2022-01-05       Impact factor: 4.277

Review 3.  Classics in chemical neuroscience: diazepam (valium).

Authors:  Nicholas E Calcaterra; James C Barrow
Journal:  ACS Chem Neurosci       Date:  2014-02-27       Impact factor: 4.418

4.  MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like properties.

Authors:  J A Miller; M W Dudley; J H Kehne; S M Sorensen; J M Kane
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.